BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 6202101)

  • 1. Indole Derivatives Obtained from Egyptian
    Amer MA; Wasfi R; Attia AS; Ramadan MA
    Antibiotics (Basel); 2021 Mar; 10(4):. PubMed ID: 33805493
    [No Abstract]   [Full Text] [Related]  

  • 2. Overview of
    Chakkour M; Hammoud Z; Farhat S; El Roz A; Ezzeddine Z; Ghssein G
    Front Microbiol; 2024; 15():1383618. PubMed ID: 38646633
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathogenic Factors Correlate With Antimicrobial Resistance Among Clinical
    Filipiak A; Chrapek M; Literacka E; Wawszczak M; Głuszek S; Majchrzak M; Wróbel G; Łysek-Gładysińska M; Gniadkowski M; Adamus-Białek W
    Front Microbiol; 2020; 11():579389. PubMed ID: 33324365
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular Analysis of Virulence Genes HpmB and rsbA among
    Mathlum Al-Khafaji K; Ayyal Mutar Alrashedi A; Al-Rubaeaee AA
    Arch Razi Inst; 2023 Aug; 78(4):1295-1303. PubMed ID: 38226368
    [No Abstract]   [Full Text] [Related]  

  • 5. Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis.
    Jacobsen SM; Stickler DJ; Mobley HL; Shirtliff ME
    Clin Microbiol Rev; 2008 Jan; 21(1):26-59. PubMed ID: 18202436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential virulence factors of Proteus bacilli.
    Rózalski A; Sidorczyk Z; Kotełko K
    Microbiol Mol Biol Rev; 1997 Mar; 61(1):65-89. PubMed ID: 9106365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemolytic activity and invasiveness in strains of Proteus penneri.
    Rozalski A; Kotełko K
    J Clin Microbiol; 1987 Jun; 25(6):1094-6. PubMed ID: 3597752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virulence determinants of uropathogenic Escherichia coli and Proteus mirabilis.
    Mobley HL; Island MD; Massad G
    Kidney Int Suppl; 1994 Nov; 47():S129-36. PubMed ID: 7869662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Swarmer cell differentiation in Proteus mirabilis.
    Rather PN
    Environ Microbiol; 2005 Aug; 7(8):1065-73. PubMed ID: 16011745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some biological features of Proteus bacilli. 1. Comparison of Proteus mirabilis strains provided from various sources.
    Kotelko K; Rozalski A; Deka M; Kaca W; Sidorczyk Z; Gromska W; Zych K
    Acta Microbiol Pol; 1983; 32(4):339-44. PubMed ID: 6202101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some biological features of Proteus bacilli. 2. Haemolytic activities of Proteus mirabilis and Proteus vulgaris strains.
    Kotelko K; Kaca W; Rózalski A; Deka M
    Acta Microbiol Pol; 1983; 32(4):345-51. PubMed ID: 6202102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some biological features of proteus bacilli. 3. Comparison of haemolytic activity of Proteus and Serratia strains.
    Rózalski A; Wykrota M
    Acta Microbiol Pol; 1986; 35(1-2):57-9. PubMed ID: 2426926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteus morgani is less frequently associated with urinary tract infections than Proteus mirabilis--an explanation.
    Senior BW
    J Med Microbiol; 1983 Aug; 16(3):317-22. PubMed ID: 6348289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary pathogenicity of Proteus mirabilis strains isolated from faeces or urine.
    Peerbooms PG; Verweij AM; Oe PL; MacLaren DM
    Antonie Van Leeuwenhoek; 1986; 52(1):53-62. PubMed ID: 3524444
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.